Abstract
Acinetobacter baumannii (Ab) is developing resistance to a variety of common antibiotics. and becomemultidrug resistant, extreme drug resistant, and pan drug resistant pathogens, requiring the identificationof new antibiotics as well as the identification of new plant compounds capable of acting against Ab.Recent research has revealed MDR Ab co-infections with COVID-19,, raising alarm bells. Sinceits isolation, Usnic acid has been investigated for a variety of pharmacological activities, includingantioxidant, antitumor, antibacterial, antifungal, antiviral, antiprotozoal, and insecticidal. ManyPlant-derived drugs show promising activity as new antimicrobial agents against multidrug resistant(MDR) strains. There is insufficient data to support the antibacterial activity of (+)-UA against MDRAcinetobacter baumannii..
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Forensic Medicine & Toxicology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
